Previous FDA reviews have “steadfastly found” that mifepristone is safe and effective, Ballou wrote in his decision.
Fifth circuit judges are set to hear arguments in a separate case, with Louisiana asking the FDA to reinstate previous restrictions that would block mail-order mifepristone and put limits on pharmacy prescriptions…
“The efforts to restrict it are not about science or safety – they are about making abortion harder to access,” said Nancy Northup, president and CEO at the center, in a statement. She called Friday’s ruling “a win for science”…
https://www.theguardian.com/us-news/2026/jul/24/fda-mifepristone-restrictions
